Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: SK Biopharmaceuticals Co., Ltd.

Capitalization 7,70600Cr 517.18Cr 448.65Cr 405.65Cr 387.33Cr 704.51Cr 48TCr 729.17Cr 4.83TCr 1.92TCr 23TCr 1.94TCr 1.9TCr 82TCr P/E ratio 2025
36.6x
P/E ratio 2026 * 28.8x
Enterprise value 741.21Cr 49.75L 43.15L 39.02L 37.26L 67.76L 46Cr 70.14L 4.64Cr 1.84Cr 22Cr 1.87Cr 1.83Cr 79Cr EV / Sales 2025
13.8x
EV / Sales 2026 * 8.01x
Free-Float
35.81%
Yield 2025 *
-
Yield 2026 * 0.1%
1 day-0.30%
1 week+0.92%
Current month-17.86%
1 month-11.75%
3 months-27.49%
6 months-10.95%
Current year-21.03%
1 week 95,200
Extreme 95200
1,06,300
1 month 95,200
Extreme 95200
1,19,800
Current year 95,200
Extreme 95200
1,27,900
1 year 86,900
Extreme 86900
1,44,100
3 years 57,600
Extreme 57600
1,44,100
5 years 50,900
Extreme 50900
1,44,100
10 years 50,900
Extreme 50900
2,69,500
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2023
Director of Finance/CFO 53 -
Corporate Officer/Principal 51 -
Director TitleAgeSince
Director/Board Member 69 27/08/2019
Director/Board Member 56 27/08/2019
Director/Board Member 54 28/03/2023
Change 5d. change 1-year change 3-years change Capi.($)
-0.30%+0.92%-6.37%+57.69% 523.19Cr
-1.40%-3.31%-18.47%-35.56% 5.59TCr
-3.75%-4.79%+5.33%+49.46% 784.58Cr
+0.26%+3.23%+3.58%-20.34% 757.1Cr
+1.42%+8.12%-16.68%+103.28% 495.52Cr
-4.63%-6.61%+61.52%+44.86% 306.45Cr
-0.98%+4.06%-14.44%-19.25% 269.45Cr
-0.61%+1.00%+42.52%+43.61% 259.13Cr
+1.00%+5.01%+325.57%+570.53% 247.39Cr
+0.37%+3.88%-3.09%+7.87% 213.46Cr
Average -0.85%-2.16%+37.95%+80.22% 944.13Cr
Weighted average by Cap. -1.13%-6.37%-0.21%+7.29%

Financials

2025 2026 *
Net sales 71TCr 48Cr 41Cr 37Cr 36Cr 65Cr 4.41TCr 67Cr 445.4Cr 176.86Cr 2.1TCr 179.05Cr 175.24Cr 7.6TCr 91TCr 61Cr 53Cr 48Cr 46Cr 83Cr 5.64TCr 86Cr 570.37Cr 226.48Cr 2.7TCr 229.29Cr 224.4Cr 9.73TCr
Net income 17TCr 12Cr 10Cr 9.19Cr 8.77Cr 16Cr 1.08TCr 17Cr 109.33Cr 43Cr 516.67Cr 44Cr 43Cr 1.86TCr 27TCr 18Cr 15Cr 14Cr 13Cr 24Cr 1.65TCr 25Cr 166.46Cr 66Cr 786.64Cr 67Cr 65Cr 2.84TCr
Net Debt -29TCr -20Cr -17Cr -15Cr -15Cr -27Cr -1.82TCr -28Cr -184.15Cr -73Cr -870.29Cr -74Cr -72Cr -3.14TCr -42TCr -28Cr -24Cr -22Cr -21Cr -38Cr -2.57TCr -39Cr -260.12Cr -103.29Cr -1.23TCr -104.57Cr -102.34Cr -4.44TCr
Logo SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.
Employees
246
Date Price Change Volume
12/26/12 98,400.00 -0.30% 2,22,674
11/26/11 98,700.00 -1.20% 2,28,407
10/26/10 99,900.00 +1.83% 1,75,966
09/26/09 98,100.00 -4.66% 2,10,458
06/26/06 1,02,900.00 -3.47% 2,13,138
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
98,400.00KRW
Average target price
1,43,785.71KRW
Spread / Average Target
+46.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A326030 Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW